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ABSTRACT Cellular metabolism can change the potency of a chemical’s tumorigenicity. 4-nitroquinoline-1-oxide
(4NQO) is a tumorigenic drug widely used on animal models for cancer research. Polymorphisms of the
transcription factor Yrr1 confer different levels of resistance to 4NQO in Saccharomyces cerevisiae. To study
how different Yrr1 alleles regulate gene expression leading to resistance, transcriptomes of three isogenic S.
cerevisiae strains carrying different Yrr1 alleles were proﬁled via RNA sequencing (RNA-Seq) and chromatin
immunoprecipitation coupled with sequencing (ChIP-Seq) in the presence and absence of 4NQO. In response
to 4NQO, all alleles of Yrr1 drove the expression of SNQ2 (a multidrug transporter), which was highest in the
presence of 4NQO resistance-conferring alleles, and overexpression of SNQ2 alone was sufﬁcient to overcome 4NQO-sensitive growth. Using shape metrics to reﬁne the ChIP-Seq peaks, Yrr1 strongly associated with
three loci including SNQ2. In addition to a known Yrr1 target SNG1, Yrr1 also bound upstream of RPL35B;
however, overexpression of these genes did not confer 4NQO resistance. RNA-Seq data also implicated
nucleotide synthesis pathways including the de novo purine pathway, and the ribonuclease reductase pathways were downregulated in response to 4NQO. Conversion of a 4NQO-sensitive allele to a 4NQO-resistant
allele by a single point mutation mimicked the 4NQO-resistant allele in phenotype, and while the 4NQO
resistant allele increased the expression of the ADE genes in the de novo purine biosynthetic pathway, the
mutant Yrr1 increased expression of ADE genes even in the absence of 4NQO. These same ADE genes were
only increased in the wild-type alleles in the presence of 4NQO, indicating that the point mutation activated
Yrr1 to upregulate a pathway normally only activated in response to stress. The various Yrr1 alleles also
inﬂuenced growth on different carbon sources by altering the function of the mitochondria. Hence, the
complement to 4NQO resistance was poor growth on nonfermentable carbon sources, which in turn varied
depending on the allele of Yrr1 expressed in the isogenic yeast. The oxidation state of the yeast affected the
4NQO toxicity by altering the reactive oxygen species (ROS) generated by cellular metabolism. The integration of RNA-Seq and ChIP-Seq elucidated how Yrr1 regulates global gene transcription in response to 4NQO
and how various Yrr1 alleles confer differential resistance to 4NQO. This study provides guidance for further
investigation into how Yrr1 regulates cellular responses to 4NQO, as well as transcriptomic resources for
further analysis of transcription factor variation on carbon source utilization.

Saccharomyces cerevisiae, baker’s yeast, is a model organism that has
been extensively studied to decipher the association between genotypes
and phenotypes. In addition to the widely used laboratory strain S288c
(Engel et al. 2014), the genomes of other yeast strains have been sequenced, which provides valuable resources to investigate how the
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genetic differences among strains contribute to phenotypic differences.
The YJM789 yeast strain was derived from a clinical isolate from an
AIDS patient with S. cerevisiae pneumonia, and its draft genome is
available (Wei et al. 2007). Genome association comparison of
YJM789 to S96, a strain derived from S288c, elucidated the genetic
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basis of strain-dependent responses to a toxic chemical, 4NQO
(Gallagher et al. 2014).
4NQO is a quinoline-derived carcinogenic drug used for cancer
research on animal models because it induces squamous cell carcinoma
in oral cavities of mice (Hawkins et al. 1994). YJM789 shows higher
resistance to 4NQO treatment than S96 does in Yeast Peptone Dextrose
(YPD) medium (Gallagher et al. 2014). Mapping of quantitative trait loci
shows that the difference in resistance to 4NQO between the two strains
was correlated with variation in the YRR1 gene, which encodes a zinc
ﬁnger transcription factor. The Yrr1 protein from YJM789, Yrr1Y, possesses a threonine at the position of 775 (T775), while the Yrr1 protein
from S96, Yrr1S, possesses an isoleucine at this position (I775). Threonine
can be phosphorylated at its hydroxyl functional group, while isoleucine
does not possess a hydroxyl group and thus cannot be phosphorylated.
However, phosphorylation could not be conﬁrmed, likely due to the
technical limitations of detection using mass spectrometry. The peptide
containing the potential phosphorylation is 4578 Da and the average
weight of the peptides is 1700 Da, and therefore would be considered
too large for detection (Rong-Mullins et al. 2017b). Combined with low
abundance of transcription factors and the length of the peptide, this
precludes the validation of this phosphorylation. Instead, a mutant protein was constructed, Yrr1IE, that mimics the strong negative charge of
phosphorylation when I775 of the S96 allele is changed into a glutamate
(I775E). The level of 4NQO resistance conferred by Yrr1IE is comparable
to that conferred by Yrr1Y and is higher than that conferred by Yrr1S.
Conversely, a single point mutation E673G in Yrr1Y can convert the
4NQO-resistant allele to a 4NQO-sensitive allele. However, combining
E673G with T775E retains 4NQO resistance conferred by Yrr1Y. This
suggests that the potential phosphorylation at T775 of Yrr1Y may play an
important role in regulating cellular responses to 4NQO.
YJM789 was isolated from a patient with multiple viral infections
being treated for pneumonia with ciproﬂoxacin, an antibacterial ﬂuoroquinolone (Tawﬁk et al. 1989). S. cerevisiae is associated with the
normal human microbiome and is typically not considered to be pathogenic. However, YJM789’s original heterozygous diploid parent
adapted to unique conditions, including a suppressed immune system
and a lack of bacterial competition. It is unknown if ciproﬂoxacin
treatment directly contributed to the 4NQO tolerance seen in this
strain, if the tolerance preexisted, or if the tolerance came about by
adapting to another condition. Several mutations within Yrr1 that
changed cellular growth in response to 4NQO also changed cellular
growth when cells were forced to respire (Gallagher et al. 2014).
The mechanisms of transcription regulation by Yrr1 have been investigated in earlier studies regarding drug resistance. Yrr1 was shown
previously to autoregulate by binding to its own promoter region
(Zhang et al. 2001). In addition, Yrr1 is also known to induce higher
expression of SNQ2, a gene encoding a multidrug transporter, in response to 4NQO (Cui et al. 1998; Le Crom et al. 2002). However,
genome-wide changes of transcription and Yrr1-binding patterns have
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not been reported to provide a comprehensive view. In this study, we
constructed three isogenic strains in the yrr1D S96 background carrying
three different Yrr1 alleles: Yrr1S, Yrr1Y, and Yrr1IE. We then conducted deep RNA-Seq as well as ChIP-Seq in conditions where Yrr1
regulates the stress response in the presence of 4NQO and glycerol.
Here, we discovered that overexpression of SNQ2 bypassed the need for
Yrr1 for 4NQO sensitivity conferred by expression of the Yrr1S allele.
While the expression of many genes changed when cells with different
alleles of Yrr1 were grown in glycerol, differences in the purine salvage
pathway and other antioxidant pathways may quench free radicals
generated as yeast shift toward respiration. In the model presented here,
4NQO was actively reduced in the presence of functioning mitochondria to produce free radicals and 4HAQO. 4NQO in the form of
4HAQO interacts directly with DNA to induce DNA oxidation. Our
data indicate that genetic variation in a single transcription factor altered the process of oxidative phosphorylation within the cell, which
accounted for the aforementioned conversion of 4NQO into a toxic
mixture of free radicals and 4HAQO. This study will not only broaden
our knowledge of the yeast metabolic response to tumorigenic drugs,
but also inform research on the drug resistance of cancer cells for other
model organisms. Furthermore, the data presented here provide a resource for the further exploration of the effect of genetic variation in a
transcription factor on the utilization of carbon sources.
MATERIALS AND METHODS
S. cerevisiae strains and plasmids
The strains and plasmids used in this study were described in Gallagher et al.
(2014) and grown in YPD (1% yeast extract, 2% peptone, and 2% dextrose).
Plasmids encoding alleles of YRR1 were under the control of endogenous
promoters and terminators in pGS35, and were maintained by the addition
of G418. The entire coding region of YRR1 was replaced by the hygromycin-resistance gene in S96 (MATa, lys5) and in FY3, an isogenic yeast
strain (MATa, ura3) (Winston et al. 1995; Goldstein and McCusker 1999;
Gallagher et al. 2014). Petite strains were generated by treating parent stains
(FY3 yrr1::URA3, YJM789, YJM789 yrr1::HYGR, S96, and S96 yrr1::HYGR)
with 1 mg/ml of ethidium bromide for 6 hr in a liquid culture and plating
on YPD. After 2 d, the colonies were replica-plated onto YP with 3%
glycerol as the sole carbon source, and colonies that failed to grow were
tested for loss of the mitochondrial-encoded COX2 gene by PCR ampliﬁcation. For serial dilution growth assays, saturated cultures were grown in
YPD, serially diluted 10-fold, and spotted onto the indicated media (RongMullins et al. 2017a). Because the S96 strain is an isogenic strain to S288c,
the sequences and annotations of S288c genome release R64-1-1 (Engel
et al. 2014) were used for RNA-Seq and ChIP-Seq analyses. SNQ2 and
PDR5 overexpression plasmids were previously published (Tsujimoto et al.
2015). Overexpression plasmids were based on yEP24 with the URA3
selectable marker and were transformed into FY3 yrr1D with pGS35.
Plasmids were maintained on Yeast Minimal (YM) media with no amino
acids and monosodium glutamate as the nitrogen source, so that
500 mg/ml G418 would select for pGS35 (KanR marker). Overexpression
plasmids of all other strains were from the MORF collection (Gelperin et al.
2005). Plasmids were maintained in FY3 yrr1D by selecting for the URA3
auxotrophy. Expression of the MORF collection is driven by the GAL
promoter. Yeast were grown in YP with 2% galactose and 0.1% dextrose
to prevent toxicity from overexpression. In YP glycerol (abbreviated as
Glyc), 2% galactose and 3% ethanol were also added to the solid media.
RNA-Seq experiment and data analysis
Each of the three untagged isogenic strains with different alleles—Yrr1S,
Yrr1Y and Yrr1IE—were grown as duplicated cultures in liquid YPD
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64

106
Oxidative stress

Purine biosynthesis
and RNR genes
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biosynthesis
Nucleotide
salvage

328
DNA damage

The condition before “/” is the numerator and the one after is the denominator for differential expression. 4NQO, 4-nitroquinoline-1-oxide; YPD, Yeast Peptone Dextrose; RNR, ribonucleotide-diphosphate reductase.
a
The genes in speciﬁc functional categories were found through Gene Ontology (GO) term search within S. cerevisiae on AmiGO2 (http://amigo2.geneontology.org/amigo): DNA damage: GO:0006974 representing “cellular response
to DNA damage stimulus”; Oxidative stress: GO:0006979 representing “response to oxidative stress”; Protein folding: GO:0006457 representing “protein folding”; Purine biosynthesis and RNR genes: GO:0006164 representing
“purine nucleotide biosynthetic process,” as well as RNR1, RNR2, RNR3, and RNR4 genes; Pyrimidine biosynthesis: GO:0006221 representing “pyrimidine nucleotide biosynthetic process”; and Nucleotide salvage: union of
GO:0043173 representing “nucleotide salvage,” GO:0043101 representing “purine-containing compound salvage,” and GO:0008655 representing “pyrimidine-containing compound salvage.”
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4NQO/YPD
4NQO
S96, 4NQO
YJM789,
4NQO/YPD
Expression
S96,
Change 4NQO/YPD
Total Per
Category
Functional
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n Table 1 The numbers of loci showing signiﬁcant (q-value < 0.05) differential expression in RNA-Seq are shown as the total of each functional category and for each comparison of
conditions (combination of YRR1 allele and growth medium)

medium with G418 to midlog phase. Each culture was diluted to early
log phase and divided into two subcultures. One subculture was incubated in liquid YPD medium with 0.25 mg/ml 4NQO, and the other
subculture was incubated without 4NQO or washed and diluted into
3% glycerol. Subcultures for each replicate were further grown for 2.5 or
10 hr, respectively. Total RNA was extracted from each subculture
(sample) and multiplexed. Unstranded paired-end cDNA libraries were
prepared using an Illumina TruSeq RNA Sample Prep Kit v2. The
libraries were sequenced on Illumina MiSeq to generate 1.30–1.99 million 76 bp read pairs for each sample. All the software parameters used
in RNA-Seq analysis were set to default unless speciﬁed otherwise.
Tophat v2.0.12 (Trapnell et al. 2009; Kim et al. 2013) was used to
map the RNA-Seq reads to the S288c genome and to generate .bam ﬁles
for the mapped reads. The reads were ﬁrst mapped to ribosomal RNA
(rRNA) and transfer RNA genes (tRNA); 1.05–1.94 million read pairs
per sample were not matched to those RNA genes, and 91.2–95.5% of
those unmatched reads were then matched to the whole gene pool of
S288c. The reads matched to rRNA and tRNA were excluded because
these RNAs tend to be extracted at high and/or variable abundances
across replicates, thus may bias the calculation of FPKM (fragments per
kilobase gene per million mapped fragments). The R-package Rsubread
v1.18.0 (Liao et al. 2013) was used to generate count tables based on the
annotations of S288c genome release R64-1-1.
DESeq2 v1.8.1 (Anders et al. 2010) was used for differential expression calculation. A q-value (p-value adjusted for multi-testing) , 0.05
was considered signiﬁcant for differential expression. In addition, noncoding RNA such as small nucleolar RNA genes were quantiﬁed but
not considered in analyses of differential expression or statistical relevance (to ChIP-Seq data). This is because many of those genes showed
low and/or variable FPKM values across replicates; hence, their quantiﬁcation results may not accurately reﬂect their actual cellular abundance. Log2(fold change) of FPKM was calculated between all the
pair-wise contrasts of conditions with a difference in only one of the
following two factors: allele and growth medium [(YPD, YPD + 4NQO
(abbreviated as 4NQO), and Glyc]. It was also calculated between the
trial of Yrr1IE in YPD and the trial of Yrr1Y in 4NQO or Glyc to test
whether the phosphomimic mutation of Yrr1IE in an absence of 4NQO
(or when cells are grown in Glyc) results in transcriptional states similar
to that of Yrr1Y in the presence of 4NQO.
Gene ontology (GO) analysis
Signiﬁcantly upregulated and downregulated genes were extracted
from the Deseq2 output using MATLAB R2016a. Their signiﬁcance
was determined using a p-value cutoff of 0.05. Subsequently, the GO
terms of the signiﬁcant genes were determined using the Yeastmine
database (Engel et al. 2014). In order to mitigate the issue of multiple
comparisons and reduce the familywise error rate, the Holm–Bonferroni
test correction (Hochberg 1988) was utilized with a p-value threshold of
0.05.
ChIP-Seq data analysis
The ChIP-Seq data using the three allelic proteins of Yrr1 was previously generated (Gallagher et al. 2014). The three Myc-tagged isogenic strains with different alleles—Yrr1S, Yrr1Y and Yrr1IE—were
subjected to the same treatments as those in the RNA-Seq experiment. Three replicate cultures were prepared for each allele and
treatment combination; immunoprecipitated DNA was sequenced
for all three cultures in each combination, and input genomic DNA
was sequenced for one culture per combination. The ChIP-enriched
and input DNA samples were sequenced as multiplexed 101 bp
paired-end libraries on an Illumina HiSequation 2000. From this,
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Figure 1 Heatmap of genes showing signiﬁcant differential expression between alleles of Yrr1 in the presence of 4NQO. Log2(fold change of
FPKM) values calculated by DESeq2 are represented in blue and red. Signiﬁcant differential expression instances are highlighted based on
q-values (p-values adjusted for multi-testing), where “” represents a q-value between 0.005 and 0.05 and “” represents , 0.005. (A) Levels of
RNA that showed the strongest change in expression between Yrr1S96 and Yrr1YJM789. (B) Levels of RNA involved in nucleotide metabolism that
changed between alleles of Yrr1. 4NQO, 4-nitroquinoline-1-oxide; FPKM, fragments per kilobase gene per million mapped fragments; YPD, Yeast
Peptone Dextrose medium.

2.08–4.21 million read pairs were generated per sample and mapped
to the S288c genome using Bowtie v2.2.3 (Langmead and Salzberg
2012) with preset “–sensitive,” resulting in alignment rates of 96.1–
99.3%. Reanalysis of the data is described below. ChIP-enriched regions (peaks) were identiﬁed using CisGenome v2.0 (Ji et al. 2008)
and MACS2 v2.1.0 (Zhang et al. 2008), and their outputs were integrated for downstream analyses (see details in the supplemental
material). Prediction of DNA motifs at potential Yrr1-binding sites
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was performed using the Gibbs Motif Sampler in CisGenome with
some manual adjustment. Sequence logos of predicted motifs were
generated using WebLogo v3.4 (Schneider and Stephens 1990;
Crooks et al. 2004). The height of each nucleotide letter represented
the posterior mean relative entropy, and the error bars represented
Bayesian 95% C.I.s. Pearson’s correlation (r-value) test was performed
on ChIP peak metrics of three consolidated peak regions and expression
values of their downstream genes using the python scipy package.

n Table 2 Three consolidated peak regions with highest conﬁdence of containing functional binding sites of Yrr1
Consolidated Peak Region
Identiﬁer
201
659
527

Motif 1

Motif 2

Chromosome

Coordinates

Sequence

Coordinates (Strand)

Sequence

Coordinates (Strand)

IV
X
VII

454940–465905
606408–607949
893849–894948

TAAACGGAAATGGG
TCATCGGAATTGAG
TACACGGAAATAGG

465396–465409 (2)
607293–607306 (+)
894482–894495 (+)

ATATAAAACAAAT
AAATACGCGGAAT
AAATAACGAAAAT

465506–465518 (+)
607347–607359 (+)
894586–894598 (+)

Microscopy
Cells were grown to midlog in YM and stained live using Mitotracker
Green and Rhodamine B hexyl ester (Y7530; Life Technologies) per the
manufacturer’s instructions. Cells were imaged for differential interference contrast and ﬂuorescence microscopy using an Eclipse 600-FN
Nikon microscope with an Apochromat 100·/1.40 NA oil immersion
objective, and a cooled charge-coupled device camera (ORCA-2;
Hamamatsu Photonics). Images were processed with MetaMorph
v7.0 software (Molecular Devices) and further processed using Image J.
Data availability
The S. cerevisiae strains used in this study are available upon request.
Supplemental Material, File S1 describes the process of determining conﬁdence in ChIP-Seq peaks based on peak shape metrics, as well as all the
supporting ﬁgure legends and tables. The RNA-Seq and ChIP-Seq data
used in this study are available at NCBI GEO with accession numbers
GSE74642 and GSE74700, respectively. The links for the two data sets
are: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE74642 and
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74700.
RESULTS AND DISCUSSION
A global view of RNA-Seq transcriptomic proﬁles for
different YRR1 alleles in the presence or absence
of 4NQO
To determine the global transcriptional change due to the presence of
different alleles of Yrr1, a transcription factor, the alleles were expressed
in the same genetic background and treated with 4NQO. A total of
6717 open reading frames (ORFs) were quantiﬁed for FPKM in RNASeq. Ten comparisons of conditions were performed to identify
differentially expressed ORFs (Table 1, Table S1, and Table S2). The
within-allele comparisons between treatments of YPD (in the absence
of 4NQO) and 4NQO for each Yrr1 allele were among those showing
the largest numbers of signiﬁcantly differentially expressed loci, with
510–909 loci signiﬁcantly up- or downregulated (Table 1 and Table S2).

Stress from 4NQO treatment induced the most dramatic transcriptomic changes. Interestingly, the comparison between Yrr1S and Yrr1Y
in the presence of 4NQO showed the smallest number of signiﬁcantly
differentially expressed loci, with only six loci signiﬁcantly up regulated
and six downregulated (Table 1 and Table S2). In contrast, there were
larger numbers of signiﬁcantly differentially expressed loci when Yrr1S
or Yrr1Y was compared to the phosphomimic allele Yrr1IE in 4NQO,
with 108–143 loci signiﬁcantly up- or downregulated (Table 1). This
suggests that the transcriptomic proﬁle of Yrr1IE was divergent from
those of Yrr1S or Yrr1Y in 4NQO. Cells carrying Yrr1IE had similar
4NQO resistance to Yrr1Y cells, both of which were higher than that
of Yrr1S cells (Gallagher et al. 2014). Because Yrr1IE was predicted
to mimic the charge of phosphorylation at T775 of Yrr1Y in response
to 4NQO, the transcriptomic proﬁle of Yrr1IE in YPD was compared to
that of Yrr1Y in 4NQO. There were substantial numbers of loci significantly upregulated (671) and downregulated (602) in this comparison.
This suggests that despite I775E mimicking the 4NQO resistance of
Yrr1Y, Yrr1IE was not simply an activated form of Yrr1Y. Despite the
I775E mutation having the same phenotype as Yrr1Y on 4NQO and our
prediction that it would behave as an irremovable phosphorylation, the
transcriptomic proﬁle of Yrr1IE in YPD was not similar to that of Yrr1Y
in 4NQO. Therefore, the phosphomimic Yrr1IE allele of Yrr1Y in
4NQO could not recapitulate all cellular effects of the YJM789 allele
for several possible reasons, such as variation in other proteins, differences in phosphorylation kinetics, or incomplete phosphorylation of
the cellular pool of the wild-type allele.
Genes involved in DNA damage and oxidative stress
responses showcase remarkable patterns of differential
expression in response to 4NQO
4NQO and its cellular metabolites are known to cause DNA damage in
eukaryotes (Arima et al. 2006; Minca and Kowalski 2011). Among the
328 genes involved in the cellular response to a DNA damage stimulus,
19–31 of them were signiﬁcantly up- or downregulated in response to
4NQO depending on the Yrr1 allele (Table 1). The upregulated genes

n Table 3 ChIP peak metrics of the three high-conﬁdence regions and expression of their downstream genes for different conditions
(combinations of Yrr1 allele and growth medium)
Consolidated Peak
Region ID
201

659

527

a

Value Type

S96, 4NQO

S96, YPD

S96-I775E, 4NQO

S96-I775E, YPD

YJM789, 4NQO

YJM789, YPD

Summit heighta
Pileup log2fca
SNQ2 FPKMb
Summit height
Pileup log2fc
RPL43B FPKM
Summit height
Pileup log2fc
SNG1 FPKM
YPP1 FPKM

177.3
0.900
144.5
267.8
1.542
1599
84.47
0.509
27.0
37.8

167.7
0.756
64.8
330.4
1.940
2071
111.6
0.553
22.8
36.8

242.6
1.084
177.6
132.0
0.751
2254
65.97
0.582
34.5
33.8

177.2
0.991
77.8
100.6
0.694
2143
65.53
0.570
26.6
29.8

238.7
1.012
199.0
260.2
1.308
1914
150.4
1.042
34.2
45.6

208.8
1.167
83.5
232.0
1.610
1931
82.12
0.556
28.3
39.2

Summit height and pileup log2fc: mean summit height and mean pileup log2(fold change) of three biologcial replicates using two model building options,
respectively (Materials and Methods). ID, identiﬁer; 4NQO, 4-nitroquinoline-1-oxide; YPD, Yeast Peptone Dextrose.
FPKM: mean fragments per kilobase of transcript length per million mapped reads of two biological replicates, determined from Rsubread counts of reads.

b
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n Table 4 Pearson’s correlation test results on ChIP peak metrics of the three high-conﬁdence regions and expression of their
downstream genes for different combinations of Yrr1 allele and growth medium

a

Summit height and pileup log2fc: mean summit height and mean pileup log2(fold change) of three biological replicates using two model building options (Materials
and Methods)
FPKM: mean Fragments Per Kilobase of transcript length per Million mapped reads of two biological replicates, determined from Rsubread counts of reads

b

encode endonucleases, helicases, and proteins involved in DNA mismatch repair. The downregulated genes encode proteins including
histones, components of chromatin remodeling complexes, DNA replication proteins, RNA polymerase II subunits, and transcription initiation proteins. Changes in the gene expression of these pathways could
compensate for 4NQO-induced damage to DNA.
Metabolic reduction of 4NQO in mammalian cells is known to generate
ROS (Varnes and Biaglow 1979; Arima et al. 2006), and therefore imposes
oxidative stress on cells. Among the 106 genes involved in the response to
oxidative stress, 32–44 of them were signiﬁcantly upregulated in response
to 4NQO, depending on which Yrr1 allele was expressed (Table 1). These
genes encode antioxidant proteins such as catalases, superoxide dismutases,
peroxidases, peroxiredoxins, and thioredoxins. The higher abundance of
these transcripts likely led to more effective reduction of ROS and thus
alleviation of 4NQO-induced oxidative stress.
Several differentially expressed genes may contribute
to differential 4NQO resistance conferred by different
Yrr1 alleles
A tractable set of 12 genes were signiﬁcantly differentially expressed
between the S96 and YJM789 alleles of Yrr1 in the presence of 4NQO. It
was hypothesized that these genes may be implicated in the differential
resistance of the two alleles, prompting further examination (Figure 1).
It is possible that subtle transcriptional differences of other genes between Yrr1S and Yrr1Y in the presence of 4NQO, despite being deemed
not signiﬁcant by our study, also contribute to the differential 4NQO
resistance conferred by the two alleles.
When considering the 12 genes with signiﬁcant expression differences between S96 and YJM789 alleles of Yrr1 under 4NQO treatment,
we examined their known functions and potential relationships to
4NQO or other chemical toxins. Several had roles consistent with the
putative interplay of resistance and carbon metabolism. Snq2 is an ABC
plasma membrane transporter that is required for resistance to many
chemicals, including 4NQO (Servos et al. 1993) and ROS (Ververidis
et al. 2001). It is also known to be regulated by Yrr1 (Cui et al. 1998; Le
Crom et al. 2002), so its differential expression indicates the detection
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capability of the study. NDI1 encodes an NADH:ubiquinone oxidoreductase and is a component of the electron transport chain (ETC) in
aerobic respiration. ACH1 encodes a protein with CoA transferase and
acetyl-CoA-hydrolase activities that appears in both the cytosol and
mitochondria (Lee et al. 1990; Fleck and Brock 2009). Expression of
NDI1 and ACH1 was signiﬁcantly lower for Yrr1Y than for Yrr1S in the
presence of 4NQO, because NDI1 and ACH1 were signiﬁcantly upregulated for Yrr1S but not for Yrr1Y in response to 4NQO (Figure 1).
Overexpression of NDI1 is known to increase the accumulation of ROS
(Li et al. 2006). Given that metabolic reduction of 4NQO generates
ROS, such an expression pattern of NDI1 may result in less accumulation of ROS, or change oxidative phosphorylation in the cell and
decrease the reduction of 4NQO, thus conferring higher 4NQO resistance in cells carrying Yrr1Y (Gallagher et al. 2014). In contrast to
NDI1, deletion of ACH1 was reported to decrease resistance to oxidative stress caused by 3 mM hydrogen peroxide (Brown et al. 2006),
suggesting that higher levels of ACH1 may lead to higher resistance to
oxidative stress. Interestingly, our data suggests an association of higher
levels of ACH1 with lower resistance to oxidative stress: cells carrying
Yrr1S, where ACH1 expression is higher than in cells carrying Yrr1Y,
are less resistant to 4NQO.
Nucleotide biosynthetic genes
The genes involved in purine nucleotide biosynthetic processes showcased interesting patterns of differential expression, both in response to
4NQO and among Yrr1 alleles (Figure 1B and Table 1). Two subgroups,
ADE genes and ribonucleotide-diphosphate reductase (RNR) genes,
displayed relatively consistent patterns within each subgroup but distinct patterns from each other (Figure 1B and Table 1). In addition, null
mutations of some genes from the two subgroups have opposite effects
on resistance to oxidative stress, as described later.
Ade proteins catalyze the de novo purine biosynthetic steps from
5-phospho-ribosyl-pyrophosphate to inosine monophosphate (IMP)
(Ade1, Ade2, Ade3, Ade4, Ade5,7, Ade6, Ade8, Ade16, and Ade17)
and from IMP to adenosine monophosphate (Ade12 and Ade13). All
the ADE genes except ADE16 were signiﬁcantly downregulated in

Figure 2 ChIP peaks shown as ChIP minus input
within the three high-conﬁdence regions and
corresponding mRNA expression. (A) SNQ2 (peak
201), (B) SNG1 and YPP1 (peak 659), and (C)
RPL36B (peak 527). The plotted data were mean
pileup values of normalized ChIP minus input
generated by MACS2, using two model-building
options for three biological replicates per combination of the YRR1 allele and growth medium
(Materials and Methods). Each plotted region is
represented as a black box together with nearby
genes shown in the University of California, Santa
Cruz Genome Browser (http://genome.ucsc.edu)
(Kent et al. 2002). (D) Heatmap showing differential RNA expression for genes SNQ2, RPL43B,
SNG1, and YPP1 near the three regions (201,
659, and 527) with high conﬁdence of containing
functional binding sites for Yrr1, among different
conditions. Log2(fold change of FPKM) values calculated by DESeq2 are represented in blue and
red. Signiﬁcant differential expression instances
are highlighted based on q-values, where “” represents between 0.005 and 0.05, and “” for
, 0.005. ChIP, chromatin immunoprecipitation;
Chr, chromosome; FPKM, fragments per kilobase
gene per million mapped fragments.

response to 4NQO for Yrr1S and Yrr1Y, and signiﬁcantly lower for
Yrr1IE than Yrr1S and Yrr1Y in YPD (Figure 1B). Both Ade16 and
Ade17 have 5-aminoimidazole-4-carboxamide ribonucleotide transformylase and IMP cyclohydrolase activities (Tibbetts and Appling 1997,
2000). ADE16 is a paralog of ADE17 with overlapping roles; the expression change of ADE17 alone may be sufﬁcient for achieving the
necessary changes in metabolic activities catalyzed by both ADE16 and
ADE17. Like the protein-folding genes discussed above, the expression
pattern of ADE genes for Yrr1IE in YPD mimicked those of Yrr1S and Yrr1Y
in 4NQO. Single null mutations of ADE1, ADE3, ADE4, ADE5, ADE7, and
ADE8 were shown to increase resistance to oxidative stress caused by 3 mM
hydrogen peroxide (Brown et al. 2006). The downregulation of ADE genes

in response to 4NQO, as shown in our data, may increase resistance to
oxidative stress caused by 4NQO.
The RNR complex catalyzes the formation of dNDP from NDP, a
rate-limiting step in dNTP synthesis. All four RNR genes were significantly upregulated in response to 4NQO for all three Yrr1 alleles
(Figure 1B). This is consistent with a previous ﬁnding that the mRNA
levels of RNR1 and RNR3 increase upon treatment with 4NQO, which
likely facilitates DNA repair during replication (Elledge and Davis
1990). Deletion of RNR1 was shown to decrease resistance to oxidative
stress caused by 2 mM hydrogen peroxide, 0.5 mM paraquat, and 100%
oxygen atmosphere (Outten and Culotta 2005). It is possible that upregulation of RNR genes copes with the oxidative stress caused by 4NQO.

Figure 3 Growth assays of yeast overexpressing
ABC transporters. S288c (FY3 yrr1D) yeast with
different alleles of Yrr1 were transformed with
either an empty plasmid (-), or a plasmid overexpressing SNQ2 or PDR5. Ten-fold serial dilutions
of yeast grown in selective media to maintain
both plasmids were spotted onto increasing
amounts of 4NQO. Plates were incubated for
3 d and photographed. 4NQO, 4-nitroquinoline1-oxide; ABC, ATP-binding cassette; YM, Yeast
Minimal.
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Figure 4 Venn diagrams of mRNAs that increase
and decrease between strains with different Yrr1
alleles grown in YPD or Glyc. (A) Expression of
genes that decrease when cells are shifted to Glyc
with different alleles of Yrr1. (B) Comparisons of
genes that decrease or increased between yeast
carrying different alleles of Yrr1 when grown in
glycerol. 4NQO, 4-nitroquinoline-1-oxide; Glyc,
glycerol; YPD, Yeast Peptone Dextrose medium.

Identiﬁcation of ChIP-Seq peaks with high conﬁdence of
being functional binding sites of Yrr1
In order to investigate binding of Yrr1 to DNA as a transcription factor
in association with its impact on gene expression, the published ChIPSeq data of Yrr1 (Gallagher et al. 2014) were reexamined together with
the RNA-Seq data in this study (Table S3). In S. cerevisiae, transcription
factors bind to speciﬁc recognition sequences upstream of genes,
known as upstream activation or repression sequences (Phillips and
Hoopes 2008; Hahn and Young 2011). No transcription factor is
known to have recognition sequences within gene bodies. However,
1083 out of 1136 narrow peak regions (deﬁned in the Materials and
Methods and supplemental material) of Yrr1 ChIP enrichment identiﬁed by CisGenome and MACS2 overlap with annotated genes in the
published S288c genome. False-positive ChIP peaks have been previously identiﬁed within highly expressed genes, i.e., “hyper-ChIPable”
regions (Teytelman et al. 2013). Therefore, to examine whether hyperChIPability exists in our Yrr1 ChIP-Seq data, expression levels of loci
overlapping with narrow peak regions of Yrr1 ChIP were compared to
those of all the loci in the RNA-Seq data (Figure S1 in File S1 and Table
S1). A considerable number of Yrr1 peaks identiﬁed by CisGenome and
MACS2 overlap with highly expressed loci, and are possibly false positives due to hyper-ChIPability. Another reason for concern over false
positives is the frequent occurrence of negative peaks (enrichment in
input over ChIP). Given the concerns, an extra screening procedure is
necessary to exclude false-positive peaks from downstream analyses.
Therefore, an in silico method was developed in this study in an attempt
to identify high-conﬁdence peaks.
Based on their shape metrics, three high-conﬁdence regions were
identiﬁed in the ChIP data set as binding sites for Yrr1 alleles (Subsection
“Determine the conﬁdence in ChIP-Seq peaks based on peak shape
metrics,” Figures S2–S4, and Tables S5–S7 in File S1, Table S3, and
Table S4). These three ChIP regions were represented using ChIP
minus input (Figure S1 in File S1) and log2(fold change) (Figure S4
in File S1). Two DNA motifs at potential Yrr1-binding sites were
predicted using the three high-conﬁdence regions (Figure S5 in File
S1 and Table 2). Motif 1 shared the consensus sequence “CGGA” (or
“TCCG” as reverse complement) with potential Yrr1-binding motifs
identiﬁed in previous studies (Le Crom et al. 2002; Morozov and Siggia
2007; Badis et al. 2008; Zhao et al. 2009; Zhu et al. 2009; de Boer and
Hughes 2011). Motif 2 did not share a consensus sequence with any
previously reported Yrr1-binding motif.
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Correlation between high-conﬁdence ChIP peaks and
the expression of their nearby genes in 4NQO
Regulation of genes by the binding of a transcription factor is assumed by
the mere presence of the transcription factor. The expression of genes
downstream of Yrr1 was further investigated. Pearson’s test was performed to investigate the correlation between the ChIP peak strengths
in the three high-conﬁdence regions (201, 659, and 527) and the expression levels (represented by FPKM values) of their nearby genes SNQ2,
RPL43B, SNG1, and YPP1 (Table 3 and Table 4). Expression of SNQ2
(FPKM values) increased signiﬁcantly, and Yrr1 binding upstream of
SNQ2 (summit height of ChIP peaks in region 201) increased in response
to 4NQO for all the three alleles Yrr1S, Yrr1IE, and Yrr1Y (Figure 2A,
Table 3, and Table S1). In addition, SNQ2 expression in 4NQO was
signiﬁcantly higher for Yrr1Y than for Yrr1S, but less when comparing
yeast grown in YPD with the Yrr1IE allele to yeast grown in 4NQO with
the Yrr1Y allele (Figure 2D, Table 3, and Table S1). This indicated that the
I775E mutation was not sufﬁcient to maximize the expression of SNQ2
on its own. Although the Yrr1IE allele could phenocopy Yrr1Y in response
to 4NQO, the mutated allele was not the same as the Yrr1Y or Yrr1S allele.
There were other variable residues in Yrr1 that were subject to regulation
in response to 4NQO, as indicated by the expression of SNQ2 by the
Yrr1Y allele in 4NQO being higher than Yrr1IE in YPD.
ChIP region 527 is located upstream of two divergent genes, SNG1
and YPP1. The protein structure of Sng1 has not yet been well characterized, but transformation of SNG1 into S. cerevisiae via a multicopy
vector conferred resistance to 4NQO (Servos et al. 1993). In addition, a
gain-of-function Yrr1 mutant increased expression of SNG1, and Yrr1
directly binds the SNG1 promoter in vitro (Le Crom et al. 2002). Our
data connected the contribution of SNG1 to 4NQO resistance and the
regulation of SNG1 by Yrr1 by showing increased Yrr1 ChIP peak
strength in region 527. The correlation between Yrr1 ChIP peak
strength (Table 3) and SNG1 expression was positive but weak in this
study (Table 4). The other gene for which ChIP region 527 is upstream,
YPP1, is essential to S. cerevisiae and encodes a vesicle-trafﬁcking protein involved in vacuole-targeted endocytosis (Flower et al. 2007). YPP1
has not been reported to contribute to 4NQO responses or to be regulated by Yrr1. There were no signiﬁcant changes of YPP1 expression in
response to 4NQO or among alleles (Figure 2D).
ChIP region 659 is located upstream of RPL43B, which encodes L43B,
a protein of the ribosomal 60S subunit. Yrr1S bound the strongest in YPD
upstream of RPL43B and Yrr1IE bound the weakest in YPD (Figure 2C).

Figure 5 Live mitochondrial staining of S96 and YJM789 yeast grown
in YPD, 4NQO, and glycerol with Mitotracker and Rhodamine B hexyl
ester. 4NQO, 4-nitroquinoline-1-oxide; DIC, differential interference
contrast; YPD, Yeast Peptone Dextrose medium.

The Yrr1S binding decreased in 4NQO compared to YPD, while Yrr1IE
binding decreased in YPD compared to 4NQO. The binding of Yrr1IE
was lowest of all the alleles. There was a modest binding increase when
yeast were grown in 4NQO. Yrr1 is not known to regulate RPL43B. RNA
levels of RPL43B decreased modestly in response to 4NQO for all three
alleles (Figure 2D and Table 3). When all the conditions were included in
one test, weak negative correlation was observed with binding and expression; however, the expression of RPL43B aligned with the comparisons of the growth of yeast in different conditions (Table 4). For
example, growth of yeast with Yrr1S was strongly inhibited in 4NQO
compared to YPD (Gallagher et al. 2014). It should be noted that expression of RPL43B decreased the most when Yrr1S was expressed in yeast
grown in 4NQO compared to YPD (Figure 2D).
Impact of overexpression of differentially expressed
genes on yeast growth in 4NQO
Several genes showed increased expression levels in yeast expressing
Yrr1Y when grown in 4NQO. To assess whether overexpression can
bypass the Yrr1S 4NQO sensitivity, genes from Figure 1A were overexpressed in yeast along with the different alleles of Yrr1 or a yrr1
knockout. Overexpression plasmids encoding SNQ2 and the related
ABC transporter PDR5 were transformed into yeast carrying four alleles of Yrr1 including Yrr1EG, which is 4NQO-sensitive. In every instance, SNQ2, but not PDR5, overexpression could rescue growth in
the presence of 4NQO, even more than yeast carrying Yrr1 4NQOresistant alleles (Figure 3). A selection of diverse genes was placed under
a GAL promoter to drive overexpression, but only SNQ2 overexpression could rescue yeast growth on 4NQO (Figure S9 in File S1). While
this does not rule out other proteins that may contribute to the 4NQO
response, this indicates that higher SNQ2 expression in 4NQO is the
major contributor to higher resistance to 4NQO. The effect of the T775
site in Yrr1 was not sufﬁcient to be the sole regulator of a well-known
target of regulation such as SNQ2, in contrast to the growth of yeast in
different conditions. Transcriptomics and ChIP-Seq are more quantitative and show that the regulation is much more complicated than a
simple growth assay previously revealed.
Impact of Yrr1 on phenotypic expression in
nonfermentable carbon sources
4NQO resistance is linked to poor growth in nonfermentable carbon
sources (Gallagher et al. 2014). To metabolize carbon sources such as

Figure 6 Growth assays of grande and petite (r) yeast (FY3 yrr1::URA3)
expressing different alleles of Yrr1 on different combinations of carbon
source and derivatives of 4NQO. All yeast contained the pYrr113xMyc plasmid, and strain labels indicate the allele of YRR1 encoded
on the plasmid. Ten-fold serial dilutions of FY3 yrr1D yeast grown in
YPD or glycerol media with 4NQO or 4HAQO supplemented with the
antioxidants GSH. Plates were incubated for 3 d and photographed.
4HAQO, 4-hydroxyaminoquinoline-1-oxide; 4NQO, 4-nitroquinoline1-oxide; GSH, glutathione; YPD, Yeast Peptone Dextrose medium.

these, yeast shift from fermentation to respiration in the mitochondria.
To understand how alleles of Yrr1 change gene expression when yeast
are grown in media that requires respiration, mRNA levels were compared between yeast with Yrr1Y, Yrr1S, or Yrr1IE alleles (Table S8).
Overall levels of mRNAs from yeast expressing Yrr1Y and Yrr1S were
more similar to each other than mRNAs from yeast expressing Yrr1IE
when shifted to glycerol (Figure 4, A and B). Between Yrr1Y and Yrr1 S
yeast, 18 mRNAs were downregulated in glycerol, including ATO3, and
87 genes were upregulated, including AAH1 and a subset of components of the ETC (COX5A, COX5B, COX6, COX8, COX9). Yrr1IE
mRNA expression was very different when comparing Yrr1Y and
Yrr1S yeast, with 497 genes decreased in expression, including ribosomal
protein-encoding genes, ribosome biogenesis genes, and ETC and
ATPase genes, as compared to z-score of log2(fold) change in expression comparing mRNA expression between yeast carrying different
alleles of Yrr1 grown in YPglyc (Table S8). Only 14 genes decreased
in the comparison between Yrr1S and Yrr1IE, and 55 genes were downregulated speciﬁcally in Yrr1IE compared to Yrr1Y.
When comparing mRNAs across strains grown in glycerol, Yrr1S
and Yrr1Y were quite similar. The expression of 418 genes that increased in unison across strains was independent of differences between
Yrr1 alleles, including mRNAs encoding components of the ATPase
(ATP1, ATP2, ATP3, ATP4, ATP5, ATP7, ATP10, ATP15, ATP16,
ATP17 and TIM11) and ETC [COR1, CYT1, (QCR2, QCR7, QCR8,
QCR9, QCR10), RIP1, SDH1, SDH2, SDH3, SDH4, SHH4, and COX1,
COX3, COX4, COX5A, COX6 and COX15.]. In comparing the Yrr1IE
allele to the wild-type alleles grown in glycerol, many genes were upregulated in the mutant. Nonetheless, Yrr1IE was more similar to Yrr1Y
than Yrr1S among genes that were upregulated. The 209 shared genes
that were upregulated in the mutant had diverse functions. In a similar
analysis of downregulated genes in the mutant compared to the wildtype alleles, 497 genes of diverse functions were downregulated Yrr1IE.
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Figure 7 Growth assays of YJM789 or S96 yeast
and different combinations of wild-type or yrr1D
mutants, and grande or petite (r) with FCCP. Tenfold serial dilutions of yeast grown YPD with
4NQO supplemented with antioxidants GSH.
Plates were incubated for 3 d and photographed.
4NQO, 4-nitroquinoline-1-oxide; FCCP, Carbonyl
cyanide-4-(triﬂuoromethoxy)phenylhydrazone; GSH,
glutathione; YPD, Yeast Peptone Dextrose medium

However, Yrr1IE was more similar to Yrr1S than Yrr1Y when comparing downregulated genes.
Direct comparisons of transcription and translation between S288c
(speciﬁcally S96) and YJM789 yeast have consistently found increased
expression of YJM789 mRNAs encoding genes involved in respiration
(Sun et al. 2016), and relative protein levels between the two strains
were also higher when YJM789 yeast were grown in the presence of
dextrose (Rong-Mullins et al. 2017). These lines of evidence indicate
that YJM789 yeast constitutively upregulates respiration mRNAs and
proteins in comparison to S96, regardless of metabolic state, even when
cells are grown in dextrose. YJM789 yeast grow slower on nonfermentable carbon sources (Gallagher et al. 2014) and have a lower electron
gradient across the mitochondrial membrane than S96 yeast (discussed
below). Cox5B expression occurs during anaerobic growth (hypoxic), as
compared to its paralog Cox5A, which is expressed during aerobic
growth (Burke et al. 1997). COX5B was increased in yeast expressing
Yrr1IE and Yrr1Y compared to Yrr1S when grown in glycerol, while
COX5A was decreased between Yrr1IE when compared to Yrr1S. Over
half of the 452 genes that were downregulated in response to growth on
glycerol were involved in ribosome biogenesis, structural ribosomal
proteins, and translation (Warner 1999; Woolford and Baserga
2013). Ribosomal mRNAs decreased the most between yeast expressing Yrr1Y, which grow poorly in this condition. Ribosome biogenesis is
a costly process, and it is quickly reduced when yeast growth slows
(Warner 1999; Woolford and Baserga 2013).
Expression of purine de novo biosynthetic pathway
during respiration
Another mRNA that was differentially expressed in yeast expressing
Yrr1IE compared to Yrr1S and Yrr1Y was AAH1. Expression of
AAH1 in Yrr1IE yeast grown in glycerol compared to YPD decreased
4 log2(fold) compared to yeast expressing other alleles [log2(fold)
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decrease]. Aah1 is an enzyme that converts adenine to hypoxathanine in the purine salvage pathway (Woods et al. 1984). While all
strains irrespective of the allele of Yrr1 downregulated many genes in
the purine de novo biosynthetic pathway in both 4NQO and glycerol,
these yeast also downregulated IMD3, while IMD4 increased, in
glycerol, genes which encode other proteins in the purine salvage
pathway (Table S1 and Table S8). Evidence from other systems
suggests that the purine salvage pathway can generate purine-based
antioxidants in the mitochondria (Becker 1993; Kristal et al. 1999).
Respiration is the primary source of endogenous ROS in yeast, and
catalase (CTT1) and mitochondrial superoxide dismutase (SOD2)
levels were also increased in yeast grown in glycerol.
Shifting yeast to different environmental conditions changed the
expression of hundreds of mRNAs. To gain perspective on the role of
different alleles of Yrr1, GO term analysis was carried out (Table S9).
Changes for each allele were compared between yeast grown in 4NQO
or glycerol, and compared to the yeast carrying the same allele of Yrr1
grown in YPD. Representative pathways were graphically represented
using the 2log of the p-value. Yeast containing Yrr1IE had the fewest
GO terms change in either condition (Figure S10 in File S1). Because
the Yrr1IE allele is thought to be in part a constitutively active allele,
these changes may reﬂect the phosphorylated state of Yrr1Y. Pathways
required for active growth, such as ribosome biogenesis, were consistently downregulated (by strain-speciﬁc extents). Yrr1IE downregulated
a similar number of genes in the ribosome biogenesis pathway across
both conditions, while Yrr1Y showed less downregulation of this pathway by comparing the number of genes in each GO term. Purine biosynthesis, amino acid activation, and IMP biosynthesis were more
downregulated in Yrr1Y compared to Yrr1S, while Yrr1IE showed no
change. There were also predictive patterns in pathways that were
upregulated compared to YPD. By comparing the number of genes
in each GO term, yeast carrying the Yrr1S allele had more genes

Figure 8 Model 4NQO metabolism in yeast. 4QNO is reduced into
4HAQO while also generating ROS. The ROS byproducts of 4NQO
metabolism can be quenched by GSH. Metabolism of 4HAQO does
not produce ROS, and so 4HAQO growth inhibition could be mitigated by
the addition of GSH. 4HAQO is conjugated to a seryl and oxidized guanine
(dG) into 8OHdG. Oxidized nucleotides in DNA are typically repaired
by base excision. Snq2 localized to the cell membrane exports 4NQO.
Increased expression of Snq2 decreases the growth inhibition by 4NQO.
4HAQO, 4-hydroxyaminoquinoline-1-oxide; 4NQO, 4-nitroquinoline-1oxide; 8OHdG, 8-Oxo-2’-deoxyguanosine; GSH, glutathione; ROS,
reactive oxygen species.

involved in cellular respiration upregulated in both 4NQO and glycerol
than Yrr1Y and Yrr1IE.
Yrr1 regulation of metabolism and growth under
nonfermentable carbon sources
Because of the differences in the growth of YJM789 and S96 in glycerol, we
assessed the function of the mitochondria from both strains. Glycerol is a
nonfermentable carbon source that requires respiration by the mitochondria to metabolize the glycerol. We examined the function of mitochondria
using vital stains. Mitotracker stains the mitochondria based on the
electron potential across the membrane, and mitochondria from
YJM789 were lightly stained compared to those from S96 (Figure 5).
In contrast, Rhodamine B hexyl ester, which stains the lipids of the
mitochondria, equally stained YJM789 and S96. Taken together with
the altered growth on glycerol, this suggested that YJM789 cells have less
oxidative phosphorylation and consequently less respiration. The mitochondrial DNA contents of these cells are the same, and although there
are SNPs between these strains in the mitochondrial genome, swapping
the mitochondria does not change growth on glycerol (Sun et al. 2016).
The ability to respire might also affect the 4NQO toxicity. We tested the
4NQO response in cells that contain mitochondria that cannot respire
(petite) by removing the mitochondrial genome. Strains were made
respiration deﬁcient (r0) and, when plated on 4NQO, they grew better
than grande yeast (r+), which were respiration-proﬁcient strains (Figure
6, top row). Here, we tested both wild-type alleles of Yrr1, Yrr1IE, and
Yrr1TE (T775E mutation in the Yrr1 allele from YJM789). We found that
more 4HAQO was required to slow the growth of such yeast, which was
consistent with our hypothesis that 4NQO toxicity was related to its
metabolism and the resultant production of ROS. 4NQO toxicity was
indeed mediated through the mitochondria, because the resistance of
yeast to 4NQO was decreased in the nonfermentable carbon source
where respiration was required (Figure 6, bottom row). To conﬁrm that
respiration was generating free radicals from 4NQO metabolism, the
antioxidant glutathione (GSH) rescued the enhanced 4NQO toxicity in

glycerol media (Figure 6, bottom row). The potentiation of 4NQO generated free radicals that were quenched by the addition of GSH. 4HAQO
toxicity was not rescued by antioxidants, further supporting the importance of respiration-induced ROS in 4NQO toxicity. Consistent with the
parent strains, the yrr1D yeast expressing mutant alleles of Yrr1 with
glutamic acid at 775 were more resistant than wild-type parental alleles
(Figure 6). All strains could be rescued from 4NQO by GSH in YPD and
were more sensitive to 4NQO when grown on glycerol. Isogenic yeast
expressing different alleles were also sensitive to 4HAQO, which could
not be rescued by the addition of GSH. Previous studies in cell lysates
have found that 4NQO conversion to 4HAQO is stimulated by oxygen,
and that metabolic activation increases when reducing compounds are
available (Blaglow et al. 1977). In human cell culture, adding GSH increases the viability of cells treated with 4NQO and decreases the production of 4HAQO (Arima et al. 2006). Altering levels in the purine
salvage pathway may also change the metabolism of 4NQO, as 4HAQOpurine adducts form (Kitani et al. 1983; Loret et al. 2007). Yrr1 has
additional roles to play in the 4NQO response because the yrr1D yeast
from both resistant and sensitive yeast has hindered growth compared to
the respective wild-type parents.
To pinpoint which stage of the ETC may be working to increase 4NQO
toxicity, drugs that block speciﬁc steps were tested in conjunction with
4NQO. Concentrations of drugs that interfere at various steps of respiration
were optimized to inhibit growth on glycerol, yet permit growth on YPD. In
this case, when grown in the presence of these drugs, yeast were unable to
respire and were functionally petite, but the ETC was stopped at different
steps based on the target of each drug. If these chemical respiration blockers
work at the same step as 4NQO, then no decreased growth inhibition would
be seen. Antimycin A blocks the transfer of electrons between cytochrome b
and cytochrome c, and decreases oxygen consumption, which occurs at
complex IV. Myxothiazol inhibits cytochrome bc1 by competing with
ubiquinol, and the effect of myxothiazol binding induces a red-shift to
the visible absorption spectrum of reduced heme bl. Oligomycin A is an
inhibitor of ATP synthase and blocks proton ﬂow. FCCP breaks the proton
gradient because it permeablizes the mitochondrial membrane and allows
electrons to ﬂow around the ATP synthase. Because this occurs after
Complex IV and possibly as the cells try to compensate for decreased ATP, the oxygen consumption of FCCP-treated cells increases
(Schnellmann 2013). There was no change in growth with antimycin A,
myxothiazol, or oligomycin A with 4NQO, but FCCP exacerbated sensitivity to 4NQO (Figure 7). Blocking the ETC causes electrons to back up,
which we posit radicalizes oxygen, increasing the damage from 4NQO
treatment. Nevertheless, the addition of GSH rescues all growth inhibition.
Gene expression patterns in 4NQO and
nonfermentable carbon sources
In the presence of 4NQO, the expression of SNQ2 was signiﬁcantly higher
in yeast with the Yrr1Y allele than with the Yrr1S allele. For all three
alleles, SNQ2 expression was not signiﬁcantly lower when the yeast cells
utilized glycerol when compared to yeast carrying those alleles grown
with dextrose as the carbon source. Because cells containing Yrr1Y grow
better than those containing Yrr1S in 4NQO (but grew less in YPglyc
media), higher expression of SNQ2 can be associated with higher resistance to 4NQO and with inhibited growth in glycerol media.
Conclusions
The role of Yrr1 in 4NQO toxicity may represent the connection between the cell’s responses to various sources of stress, such as nutrient
availability (carbon source) and xenobiotics (4NQO), leading us to
propose a metabolic model for 4NQO mechanism (Figure 8). In yeast
that actively respire, 4NQO is more toxic because of the production of
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both 4HAQO and ROS, and growth can be rescued by the addition of
GSH, which quenches the ROS but not the 4HAQO effects. GSH
reduces ROS, and can be directly conjugated to 4NQO products
(Peklak-Scott et al. 2005) and then transported out of the cell by
Snq2. The addition of 20 times more 4HAQO was required to inhibit
yeast growth to the same extent as 4NQO, so most of 4NQO’s toxicity
can be traced to the process of conversion, not the 4HAQO metabolite
itself. Petite yeast cannot respire and hence were more resistant to
4NQO because 4NQO was not converted. Conversely, forcing yeast
to respire increased the toxicity of 4NQO. The unexpected relative
resistance to 4NQO of petite yeast illustrated that shifting the carbon
metabolism and by proxy the redox state of yeast altered 4NQO response. In other words, repressing respiration increased 4NQO resistance, whether that was by actively preventing respiration in petite cells
or expressing alleles of Yrr1 that cause yeast to respire less. Because
petite 4NQO-resistant yeast could not grow on a nonfermentable carbon source, it is a most extreme example of reduced growth on a nonfermentable carbon source compared to the only slowed growth of
Yrr1Y-carrying yeast in similar conditions. The variation in gene expression among yeast with different Yrr1 alleles was a combination of
direct regulation and indirect change. The indirect change in gene
expression involved general pathways, which were downregulated in
response to stress.
In an effort to correlate ChIP-Seq and transcriptomics in a variety of
environmental conditions, we assessed changes in gene expression induced by different alleles of a single transcription factor. While a single
polymorphism can ﬂip a 4NQO-sensitive allele to a 4NQO-resistant allele
by inducing the transcription of Snq2, the simplicity of this model did not
translate well to the growth of yeast in glycerol. The expression of Yrr1Y
conferred a productive transcriptional response to 4NQO, but slowed the
growth of yeast in nonfermentable carbon sources. The Yrr1IE allele
increased the 4NQO resistance more than either wild-type allele; however, examination of the transcriptomic data revealed signiﬁcant differences in genome-wide expression between the Yrr1IE and Yrr1Y alleles,
despite similar phenotypes in 4NQO. There are likely additional modes
of Yrr1 regulation, in particular when cells are grown in glycerol, which
precluded the correlation of ChIP-Seq of a single transcription factor and
changes in the transcriptome. The changes in the transcriptome between
three different conditions with the different alleles of Yrr1 combine not
only inputs from Yrr1, but also regulators that respond to these conditions. The transcriptomic data set produced here can be further used for
the analysis of expression variation in different carbon sources due to
genetic variation in a single transcription factor.
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